Project Grant R61DA061831

Award Date 9/30/24
Completion Date 8/31/26
Dollars Obligated $3.1M
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Lexington, KY 40526, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), aims to optimize the delivery of pre-exposure prophylaxis (PrEP) care for people who inject drugs (PWID) in rural Kentucky. The $1,334,540 grant, awarded on September 30, 2024, will fund a Sequential Multiple Assignment Randomized Trial (SMART) to test adaptive intervention strategies to improve PrEP initiation and persistence among this underserved...
This $1,519,496 federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will fund a study to test the effectiveness of the PATH (Peer Advanced Training in Harm Reduction) workforce intervention. The intervention uses virtual education and case-based learning to support Peer Recovery Support Specialists (PRSS) who deliver harm reduction services. The goal is to reduce burnout among PRSS and (secondarily) improve service...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and evaluate a technology-based intervention to encourage protective behaviors against drug overdose, such as drug checking, distribution of harm reduction supplies, and linkage to services. The total award amount is $1,607,146 over a 2-year period from September 2024 to August 2026. The project will be led by the non-profit organization...
The National Institute on Drug Abuse (NIDA) awarded a $2,316,128 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Regents of the University of Minnesota. The grant aims to design tailored harm reduction strategies to address the heterogeneous nature of the overdose crisis across six distinct jurisdictions. Building on previous work optimizing naloxone distribution, the project will collaborate with health departments and community partners to assess the...
This $3,503,736 federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support the development and testing of a multilevel substance use disorder (SUD) and overdose prevention strategy for rural youth involved in the county legal system. The 2-year R61 phase will co-design the multilevel SUD/overdose prevention strategy and an implementation plan for rural juvenile court systems. The subsequent 3-year...
This federal Project Grant award of $157,684 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund a study to understand disparities in harm reduction services provided to persons with opioid use disorder in hospital settings. The key products and services to be delivered include: Developing and validating a natural language processing (NLP) system to identify patterns of harm reduction language and other relevant data from...
This $1,948,634 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and evaluation of the "OD-CHESS" mobile health (mHealth) intervention to reduce overdose risk among people who engage in polysubstance use. The project has two main phases: 1) Developing the OD-CHESS intervention by adapting an existing substance use disorder app in partnership with people who use drugs and local...
This $1,192,612 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support a multidisciplinary effort to integrate HIV prevention services into clinical care settings for people with opioid use disorder (OUD). The key objectives are to: 1) conduct a systematic assessment of healthcare utilization, HIV prevention services, and medication for OUD (MOUD) using claims and emergency department data; 2) use an...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), totaling $444,826, is focused on adapting and testing an innovative, trauma-informed intervention to reduce overdose risk among women re-entering the community from prison. The key activities include: 1) Adapting the Trust-Based Relational Intervention (TBRI) approach by engaging stakeholders to align it with the unique needs of justice-involved women,...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $3,189,610.00 to the Regents of the University of Michigan to develop and test a novel "Coalition for Harm Reduction and Prevention" (CHRP) hub-and-spoke model. This model aims to help rural outpatient clinics in Michigan adopt effective prevention and harm reduction services, with a focus on reducing disparities, to address the...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will provide $3,067,394.00 to test an innovative, peer-driven "intravention" approach to address unmet harm reduction needs in two rural Kentucky counties affected by the opioid/stimulant epidemic. The project, titled "Engaging People Who Use Drugs in Harm Reduction Service Delivery," aims to reduce the risk of overdose, hepatitis C, skin and soft tissue infections, and HIV among people who inject drugs in the targeted rural Appalachian region. The award will support the co-development and tailoring of the peer-driven "ASSIST" intravention, which will engage people who use drugs as interventionists to reach individuals with unmet harm reduction needs. The project will evaluate the impact of the ASSIST intravention on substance use-related harms and implementation outcomes using a hybrid effectiveness study, cost-effectiveness analysis, and mathematical modeling. The findings are expected to advance harm reduction science and inform scale-up efforts in rural Appalachian communities and beyond.

Generated 7/1/25, 3:18 AM